Cardlytics, Inc.·4

May 19, 4:21 PM ET

Evans David Thomas 4

Research Summary

AI-generated summary

Updated

Cardlytics (CDLX) CFO David Evans Buys 200,000 Shares

What Happened
David Thomas Evans, Chief Financial Officer of Cardlytics (CDLX), reported open-market purchases of a total of 200,000 shares: 150,000 shares on 2026-05-15 at a weighted average price of $0.65 (total $97,350) and 50,000 shares on 2026-05-18 at a weighted average price of $0.63 (total $31,650). These were purchases (transaction code P), representing insider buys rather than sales.

Key Details

  • Transaction dates and prices:
    • 2026-05-15 — 150,000 shares @ weighted avg $0.65 (prices ranged $0.639–$0.650) — $97,350
    • 2026-05-18 — 50,000 shares @ weighted avg $0.63 (prices ranged $0.627–$0.639) — $31,650
  • Total purchased: 200,000 shares for ~$129,000.
  • Shares owned after transaction: not disclosed in the information provided in this summary (refer to the full Form 4 for post-transaction holdings).
  • Footnotes: Both purchases use weighted-average pricing and include undertakings to provide the breakdown of individual trade prices on request (see ranges above).
  • Filing timeliness: Form 4 filed 2026-05-19 — within the standard two business-day filing window for these transactions.

Context
These were straightforward open-market purchases (no option exercises, awards, or gifts). Insider purchases can be interpreted as a positive (insiders buying their company’s stock), but the total dollar amount here (~$129k) is modest; interpret accordingly and consult the full Form 4 for complete holdings and disclosures.